Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL–TAMO Study Group-Reference-Cited by-同舟云学术

Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL–TAMO Study Group

Published:2008-03 Issue:3 Volume:80 Page:227-235
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Arranz Reyes,Conde Eulogio,Grande Carlos,Mateos Maria Victoria,Gandarillas Marco,Albo Carmen,Lahuerta Juan J.,Fernández-Rañada José M.,Hernández Miguel T.,Alonso Natalia,García Vela José A.,Garzón Sebastián,Rodríguez José,Caballero Dolores,

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2007.01020.x/fullpdf

Reference37 articles.

1. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

2. Prognostic models for diffuse large b-cell lymphoma

3. Autotransplantation in Lymphoma: Better Therapy or Healthier Patients?

4. International Consensus Conference on High-Dose Therapy With Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report of the Jury

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RETRACTED ARTICLE: High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey;International Journal of Hematology;2019-11-16

2. Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial;British Journal of Haematology;2014-07-28

3. HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma;Blood;2013-08-22

4. Clinical Applications of BAC Array-CGH to the Study of Diffuse Large B-Cell Lymphomas;Methods in Molecular Biology;2013

5. Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA;Haematologica;2011-05-05